Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADIL Adial Pharmaceuticals

Closed 05-20 16:00:00 EDT

1.50

-0.05

-3.25%

盘后1.50

+0.00-0.04%

19:58 EDT

High1.57	Low1.48	Vol43.12K
Open1.55	D1 Closing1.55	Amplitude5.83%
Mkt Cap6.08M	Tradable Cap5.90M	Total Shares4.05M
T/O65.38K	T/O Rate1.10%	Tradable Shares3.94M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ADIL","market":"US","secType":"STK","nameCN":"Adial Pharmaceuticals","latestPrice":1.4996,"timestamp":1716235200000,"preClose":1.55,"halted":0,"volume":43121,"hourTrading":{"tag":"盘后","latestPrice":1.499,"preClose":1.4996,"latestTime":"19:58 EDT","volume":633,"amount":937.372,"timestamp":1716249483459},"delay":0,"floatShares":3937338,"shares":4054861,"eps":-4.579429,"marketStatus":"Closed","change":-0.0504,"latestTime":"05-20 16:00:00 EDT","open":1.55,"high":1.57,"low":1.4797,"amount":65383.725485,"amplitude":0.058258,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.579429,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1716278400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1532664000000,"exchange":"NASDAQ","adjPreClose":1.55,"preHourTrading":{"tag":"盘前","latestPrice":1.54,"preClose":1.55,"latestTime":"09:07 EDT","volume":840,"amount":1268.152368,"timestamp":1716210427850},"postHourTrading":{"tag":"盘后","latestPrice":1.499,"preClose":1.4996,"latestTime":"19:58 EDT","volume":633,"amount":937.372,"timestamp":1716249483459},"volumeRatio":0.268861},"requestUrl":"/m/hq/s/ADIL/","defaultTab":"news","newsList":[{"id":"2435864678","title":"Adial Pharmaceuticals reports Q1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2435864678","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435864678?lang=en_us&edition=fundamental","pubTime":"2024-05-16 13:36","pubTimestamp":1715837813,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals press release : Q1 net Loss was $6.5 million for the three months ended March 31, 2024, compared to a net loss of $2.9 million for the three months ended March 31, 2023.  Cash and cash equivalents were $5.0 million as of March 31, 2024, compared to $2.8 million as of December 31, 2023.  The company believes that its existing cash and cash equivalents will allow it to accelerate the development of AD04 and fund its operating expenses into the first quarter of 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4107079-adial-pharmaceuticals-reports-q1-results","is_publish_highlight":false,"gpt_icon":0},{"id":"2435378706","title":"Adial Pharmaceuticals Q1 EPS $(2.19) Misses $(0.35) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2435378706","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2435378706?lang=en_us&edition=fundamental","pubTime":"2024-05-15 20:45","pubTimestamp":1715777128,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(2.19) per share which missed the analyst consensus estimate of $(0.35) by 525.71 percent. This is a 20.36 percent increase over losses of $(2.75) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38842909/adial-pharmaceuticals-q1-eps-2-19-misses-0-35-estimate","is_publish_highlight":false,"gpt_icon":0},{"id":"2435325036","title":"Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2435325036","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2435325036?lang=en_us&edition=fundamental","pubTime":"2024-05-15 12:30","pubTimestamp":1715747400,"startTime":"0","endTime":"0","summary":"GLEN ALLEN, Va., May  15, 2024  (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies fo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/15/2882424/26135/en/Adial-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433005725","title":"Adial Pharmaceuticals Inc    expected to post a loss of 33 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2433005725","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2433005725?lang=en_us&edition=fundamental","pubTime":"2024-05-08 21:06","pubTimestamp":1715173566,"startTime":"0","endTime":"0","summary":"* Adial Pharmaceuticals Inc     is expected to show no change in quarterly revenue when it reports  results on May 10 (estimated) for the period ending March 31 2024   *    * LSEG's mean analyst estim","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430735179","title":"Adial Pharmaceuticals Finalizes Separation Agreement with Dr. Johnson","url":"https://stock-news.laohu8.com/highlight/detail?id=2430735179","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2430735179?lang=en_us&edition=fundamental","pubTime":"2024-04-27 04:13","pubTimestamp":1714162428,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals Inc (ADIL) just unveiled an announcement. Adial Pharmaceuticals, Inc. has finalized a Separation Agreement with Dr. Bankole A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-finalizes-separation-agreement-with-dr-johnson?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-finalizes-separation-agreement-with-dr-johnson?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2429292700","title":"EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2429292700","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2429292700?lang=en_us&edition=fundamental","pubTime":"2024-04-22 22:00","pubTimestamp":1713794433,"startTime":"0","endTime":"0","summary":"On April 16, 2024, the United States Patent and Trademark Office issued patent number 11957664 toAdial Pharmaceuticals Inc.This patent expands Adial’s intellectual property protection and covers the combination of the company’s proprietary genetic diagnostic to identify patients with specific genotypes for genetically targeted treatment of alcohol use disorder  and other drug dependencies, such as opioid use disorder , with the company’s lead investigational new drug product AD04.Related:EXCLUSIVE: Adial Pharmaceuticals Announces New US Patent Covering Its Molecular Genetic Diagnosing For Alcohol, Drug Dependence.Cary Claiborne, CEO of Adial, commented, “We are proud to have secured this new patent, which covers important aspects of the combination of our proprietary genetic diagnostic and AD04 to treat AUD, OUD, and other drug dependencies.”In February, Adial Pharmaceuticals received a U.S. patent allowance covering AD04 and its ability to target the serotonin transporter gene for the","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Nzyfj4s_CFNq.tHG_vhLTQ--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/6b6c4085efafde1f7cc0ccd31ff55453","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Nzyfj4s_CFNq.tHG_vhLTQ--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/6b6c4085efafde1f7cc0ccd31ff55453"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-alcohol-disorder-focused-adial-140033291.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429923965","title":"BRIEF-Adial Pharmaceuticals Granted Key Patent From The United States Patent And Trademark Office","url":"https://stock-news.laohu8.com/highlight/detail?id=2429923965","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2429923965?lang=en_us&edition=fundamental","pubTime":"2024-04-22 20:37","pubTimestamp":1713789464,"startTime":"0","endTime":"0","summary":"April 22 (Reuters) - Adial Pharmaceuticals Inc   :   * ADIAL PHARMACEUTICALS GRANTED KEY PATENT FROM THE UNITED STATES PATENT AND TRADEMARK OFFICESource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429392801","title":"Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office","url":"https://stock-news.laohu8.com/highlight/detail?id=2429392801","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2429392801?lang=en_us&edition=fundamental","pubTime":"2024-04-22 12:30","pubTimestamp":1713760200,"startTime":"0","endTime":"0","summary":"GLEN ALLEN, Va., April  22, 2024  (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/04/22/2866860/26135/en/Adial-Pharmaceuticals-Granted-Key-Patent-from-the-United-States-Patent-and-Trademark-Office.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428452389","title":"BRIEF-Adial Pharmaceuticals Files For Common Stock Offering Of Up To $4.3 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2428452389","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2428452389?lang=en_us&edition=fundamental","pubTime":"2024-04-19 05:35","pubTimestamp":1713476102,"startTime":"0","endTime":"0","summary":"April 18 (Reuters) - Adial Pharmaceuticals Inc   :   * ADIAL PHARMACEUTICALS INC FILES FOR COMMON STOCK OFFERING OF UP TO $4.3 MILLION - SEC FILINGSource text for Eikon: [ID: Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428982383","title":"Adial Pharmaceuticals Announces CMO’s Departure and Leadership Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2428982383","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2428982383?lang=en_us&edition=fundamental","pubTime":"2024-04-17 04:52","pubTimestamp":1713300759,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals Inc (ADIL) has issued an update. Adial Pharmaceuticals, Inc. has announced the termination of its consulting agreement with D...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-announces-cmos-departure-and-leadership-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-announces-cmos-departure-and-leadership-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2427606009","title":"Marinus Pharmaceuticals, Cartesian Therapeutics, Adial Pharmaceuticals among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2427606009","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2427606009?lang=en_us&edition=fundamental","pubTime":"2024-04-15 22:00","pubTimestamp":1713189631,"startTime":"0","endTime":"0","summary":"Gainers: Longeveron LGVN +66%. Organovo Holdings ONVO +38%. Adial Pharmaceuticals  +12%. Envoy Medical  +11%. Cartesian Therapeutics  +11%.  Losers: Marinus Pharmaceuticals  -76%. Viracta Therapeutics VIRX -25%. ProMIS Neurosciences  -21%. Neumora Therapeutics NMRA -18%. Rallybio  -13%.  S&P 500 Health Care Sector +0.99% to 1634.94. Health Care Equipment & Services +1.15% to 1905.2. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.84% to 1334.93.  More on Health Care Select Sector SPDR  XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March Drug shortages in U.S. at highest level on record since 2001","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4089641-marinus-pharmaceuticals-cartesian-therapeutics-adial-pharmaceuticals-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2427750418","title":"Adial Pharmaceuticals files to sell 2.37M common shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2427750418","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2427750418?lang=en_us&edition=fundamental","pubTime":"2024-04-13 04:35","pubTimestamp":1712954100,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals on Friday filed a prospectus related to the proposed resale of 2.37M common shares by the selling stockholders.This prospectus is not an offer to sell these securities.More on Adial Pharmaceuticals  Adial stock rallies 81% on data for alcohol abuse drug Seeking Alpha’s Quant Rating on Adial Pharmaceuticals","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4089367-adial-pharmaceuticals-files-to-sell-237m-common-shares-for-holders","is_publish_highlight":false,"gpt_icon":0},{"id":"2427581477","title":"DCFC, HUSA and INDO among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2427581477","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2427581477?lang=en_us&edition=fundamental","pubTime":"2024-04-13 01:09","pubTimestamp":1712941741,"startTime":"0","endTime":"0","summary":"Gainers: PaxMedica  +101%. Trio Petroleum Corp.  +87%. Indonesia Energy Corp Ltd  +86%. Houston American Energy Corp  +48%. HNR Acquisition Corp  +44%. EZGO Technologies Ltd  +42%. Beneficient  +38%. Brooge Energy Limited  +32%.  NextPlat Corp  +29%. Global Gas Corp  +28%.  Losers: C3is  -36%. NFT Ltd.  -25%. Soluna Holdings  -27%. Monogram Orthopaedics  -27%. Rallybio Corp  -20%. Li-Cycle Holdings Corp  -18%. MediaCo Holding  -16%. Tritium DCFC Limited  -18%. Kuke Music Holding Ltd  -16%. Adial Pharmaceuticals  -14%.   More on Mid-day movers & stocks.  Tritium receives Nasdaq Staff Determination letter Tritium confirms effective date of reverse stock split Seeking Alpha’s Quant Rating on Tritium DCFC Historical earnings data for Tritium DCFC Financial information for Tritium DCFC","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4089326-dcfc-husa-and-indo-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":1},{"id":"2426373894","title":"Veru, Theravance Biopharma, Adial Pharmaceuticals among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2426373894","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2426373894?lang=en_us&edition=fundamental","pubTime":"2024-04-12 22:00","pubTimestamp":1712930450,"startTime":"0","endTime":"0","summary":"Gainers: Allarity Therapeutics  +36%. Q32 Bio QTTB +15%. Entera Bio  +16%. Mobile-health Network Solutions  +13%. Theravance Biopharma  +11%.  Losers: Monogram Orthopaedics  -23%. Rallybio  -13%. Veru  -12%. Adial Pharmaceuticals  -8%. Agenus AGEN -8%.  S&P 500 Health Care Sector -0.49% to 1643.79. Health Care Equipment & Services -0.64% to 1909.42. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is -0.84% to 1334.42.  More on Health Care Select Sector SPDR  XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Drug shortages in U.S. at highest level on record since 2001 Cardinal Health, Cigna, Merck among top healthcare Quant picks ahead of Q1 earnings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4089269-veru-theravance-biopharma-adial-pharmaceuticals-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2426789798","title":"LPCN, ADIL and CADL among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2426789798","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2426789798?lang=en_us&edition=fundamental","pubTime":"2024-04-12 20:32","pubTimestamp":1712925165,"startTime":"0","endTime":"0","summary":"Losers: Monogram Orthopaedics (MGRM) -15%.Rallybio Corp (RLYB) -13%.Adial Pharmaceuticals (ADIL) -13%.Lipocine (LPCN) -11%.Bit Origin Ltd (BTOG) -10%.GCT Semiconductor Holding (GCTS) -9%.Eliem Therapeutics (ELYM) -9%.MediaCo Holding (MDIA) -8%.SciSparc Ltd (SPRC) -8%.Candel Therapeutics (CADL) -7%.Applied Digital Corporation APLD-6%after Q3 earnings release.Rent the Runway (RENT) -7%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4089218-lpcn-adil-and-cadl-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0},{"id":"2426262881","title":"Analysts Conflicted on These Healthcare Names: ADC Therapeutics (ADCT), Adial Pharmaceuticals (ADIL) and Steris (STE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2426262881","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2426262881?lang=en_us&edition=fundamental","pubTime":"2024-04-11 23:30","pubTimestamp":1712849425,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ADC Therapeutics (ADCT – Research Report), Adial P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-adc-therapeutics-adct-adial-pharmaceuticals-adil-and-steris-ste?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-adc-therapeutics-adct-adial-pharmaceuticals-adil-and-steris-ste?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2426259074","title":"HYMC, BSGM and ADIL are among premarket gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2426259074","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2426259074?lang=en_us&edition=fundamental","pubTime":"2024-04-11 20:27","pubTimestamp":1712838470,"startTime":"0","endTime":"0","summary":"Gainers: Rallybio  +89% shares gain on investment from J&J for rare fetal condition treatment  Eliem Therapeutics  +57% to buy Tenet, announces $120 million private placement  Biosig Technologies  +39%. Alpine Immune Sciences  +37%. Rent the Runway  +29% Q4 earnings call release  Vera Therapeutics  +11%. BitFuFu  +9%. Hycroft Mining Holding  +8%. Mobile-health Network  +7%. Zooz Power  +7%. Babcock & Wilcox Enterprises  +7% raises FY24 adjusted EBITDA target to $105M to $115M  Energy Focus  +6%. Adial Pharmaceuticals  +6%. Rail Vision  +6% gets $1 mln order out of contract valued at up to $5 mln  Iczoom Group  +5%.   More on premarket gainers & stock  Adial stock rallies 81% on data for alcohol abuse drug BioSig Technologies to reduce its internal workforce to cut down costs Seeking Alpha’s Quant Rating on Adial Pharmaceuticals Historical earnings data for Adial Pharmaceuticals Financial information for Adial Pharmaceuticals","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4088880-hymc-bsgm-and-adil-are-among-premarket-gainers","is_publish_highlight":false,"gpt_icon":0},{"id":"2426416344","title":"Adial Stock Rallies 71% on Data for Alcohol Abuse Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2426416344","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2426416344?lang=en_us&edition=fundamental","pubTime":"2024-04-10 23:13","pubTimestamp":1712762031,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals  stock rallied 81% in morning trading Wednesday amid the publication of encouraging data for the company's alcohol use disorder drug AD04. The data were featured in an article that highlighted the drug’s clinical trial results, positive safety profile and high compliance rate amongst patients. The article was published in the European Journal of Internal Medicine and is also available online through Open Access.  Adial said the article also included study results that showed low-dose AD04 did not significantly change certain liver injury biomarkers, including ALT, AST and serum bilirubin. GGT levels, which are generally associated with increased alcohol use, also remained unaffected by low-dose AD04.  More on Adial Pharmaceuticals  Seeking Alpha’s Quant Rating on Adial Pharmaceuticals Historical earnings data for Adial Pharmaceuticals Financial information for Adial Pharmaceuticals","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4088619-adial-stock-rallies-81-on-data-for-alcohol-abuse-drug","is_publish_highlight":true,"gpt_icon":1},{"id":"2426418426","title":"Adial Pharmaceuticals Shares Rise 78% After Positive Trial Data for AD04","url":"https://stock-news.laohu8.com/highlight/detail?id=2426418426","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2426418426?lang=en_us&edition=fundamental","pubTime":"2024-04-10 22:30","pubTimestamp":1712759400,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals shares were up 78% at $2.01 after the company provided promising clinical results, strong safety profile and high compliance among patients administered AD04, or low-dose ondansetron.The stock hit its 52-week low of 77 cents on Feb. 23, and is down 73% in the past 12 months.AD04 is the company's lead investigational new drug product, being developed for the treatment of alcohol use disorder.The biopharmaceutical company said the study provided a comprehensive analysis of the liver safety profile of AD04 compared to a placebo in individuals with AUD and a specific 5-marker genetic profile.According to the study, low-dose AD04 didn't significantly change biochemical markers of liver injury. No significant adverse effects were observed due to oral low-dose AD04 treatment.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adialpharma.com","stockEarnings":[{"period":"1week","weight":0.0333},{"period":"1month","weight":-0.3319},{"period":"3month","weight":0.3478},{"period":"6month","weight":-0.2619},{"period":"1year","weight":-0.8084},{"period":"ytd","weight":-0.1667}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.11348},{"month":2,"riseRate":0.333333,"avgChangeRate":0.054105},{"month":3,"riseRate":0,"avgChangeRate":-0.126633},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.03704},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.085559},{"month":6,"riseRate":0.4,"avgChangeRate":-0.06875},{"month":7,"riseRate":0.6,"avgChangeRate":0.042685},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.0672},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.042051},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.202111},{"month":11,"riseRate":0.5,"avgChangeRate":0.202877},{"month":12,"riseRate":0.333333,"avgChangeRate":0.057024}],"exchange":"NASDAQ","name":"Adial Pharmaceuticals","nameEN":"Adial Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Adial Pharmaceuticals(ADIL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Adial Pharmaceuticals,ADIL,Adial Pharmaceuticals股票,Adial Pharmaceuticals股票老虎,Adial Pharmaceuticals股票老虎国际,Adial Pharmaceuticals行情,Adial Pharmaceuticals股票行情,Adial Pharmaceuticals股价,Adial Pharmaceuticals股市,Adial Pharmaceuticals股票价格,Adial Pharmaceuticals股票交易,Adial Pharmaceuticals股票购买,Adial Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Adial Pharmaceuticals(ADIL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction